: GSK and CureVac join forces to develop vaccines targeting new COVID-19 variants 2 de fevereiro de 2021 by r4ibom in Uncategorized GSK and CureVac said their approach could potentially tackle multiple coronavirus strains in one vaccine shot Compartilhe isso: Clique para compartilhar no X(abre em nova janela) 18+ Clique para compartilhar no Facebook(abre em nova janela) Facebook 2 de fevereiro de 2021
